Hyoung Jin Kang

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial

Hyoung Jin Kang, Susan Loftus, Arlene Taylor et al. · The Lancet Oncology · 2015 · 95 citations

Drug Safety, Chemotherapy-induced Nausea, Pediatric Epidemiology +5

Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma

Kyu Han Kim, Tae Hyun Choi, Yunhee Choi et al. · JAMA Dermatology · 2017 · 59 citations · Full text

Pediatric Spinal Epidural Lymphoma Presenting with Compressive Myelopathy: A Distinct Pattern of Disease Presentation

Yun‐Sik Dho, Hyoungmin Kim, Kyu‐Chang Wang et al. · World Neurosurgery · 2018 · 13 citations

Spinal Cord Injury, Spinal Tumor, Disease Presentation +3

Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease: the REACH4 study

Franco Locatelli, Hyoung Jin Kang, Bénedicte Bruno et al. · Blood · 2024 · 13 citations · Full text

Aprepitant for the prevention of chemotherapy‐induced nausea and vomiting in paediatric subjects: An analysis by age group

Hyoung Jin Kang, Susan Loftus, Cara DiCristina et al. · Pediatric Blood & Cancer · 2018 · 10 citations